Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (65)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  2. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  3. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  4. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  5. Erratum: Hemorrhage, disseminated intravascular coagulopathy, and thrombosis complications among critically ill patients with COVID-19: An International COVID-19 Critical Care Consortium Study (Critical Care Medicine (2023) 51 (619-631) DOI: 10.1097/CCM.0000000000005798)

    Critical Care Medicine

  6. Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications among Critically Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study∗

    Critical Care Medicine, Vol. 51, Núm. 5, pp. 619-631

  7. Hyperglycemia in Acute Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 51-56

  8. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  9. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 1, pp. 55-64

  10. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients

    Frontiers in Medicine, Vol. 8

  2. Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward

    Archivos de Bronconeumologia

  3. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection

    Biomedicine and Pharmacotherapy, Vol. 154

  4. Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study

    The European respiratory journal, Vol. 59, Núm. 2

  5. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  6. Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS

    Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 1537-1549

  7. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study

    Critical care (London, England), Vol. 26, Núm. 1, pp. 18

  8. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240